NYSEARCA:IBDS iShares iBonds Dec 2027 Term Corporate ETF (IBDS) Price, Holdings, & News $24.04 -0.01 (-0.04%) (As of 12/16/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnership About iShares iBonds Dec 2027 Term Corporate ETF (NYSEARCA:IBDS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IBDS alerts:Sign Up Key Stats Today's Range$24.04▼$24.0650-Day Range$23.98▼$24.2252-Week Range$23.44▼$24.68Volume308,086 shsAverage Volume434,220 shsMarket Capitalization$2.35 billionAssets Under Management$2.70 billionDividend Yield2.79%Net Expense Ratio0.10%Aggregate RatingN/A ETF OverviewThe iShares iBonds Dec 2027 Term Corporate ETF (IBDS) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a Bloomberg global index of USD-denominated, investment-grade corporate bonds maturing between December 31, 2026 and December 16, 2027. IBDS was launched on Sep 12, 2017 and is managed by BlackRock.Read More… iShares iBonds Dec 2027 Term Corporate ETF ExpensesTypeIBDSInvestment Grade ETFsFixed Income ETFsNYSEARCA ETFsAll ETFsManagement Fee0.10%0.22%0.33%0.51%0.52%Other Expenses0.00%0.12%0.27%0.57%0.53%Total Expense0.10%0.25%0.40%0.73%0.70%Fee Waiver0.00%-0.15%-0.25%-0.67%-0.56%Net Expense0.10%0.23%0.36%0.57%0.59% Receive IBDS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares iBonds Dec 2027 Term Corporate ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address IBDS ETF News HeadlinesiShares iBonds Dec 2031 Term Treasury ETF declares monthly distribution of $0.0667October 3, 2024 | msn.comiShares iBonds Dec 2027 Term Corporate ETF declares monthly distribution of $0.0891October 3, 2024 | msn.comWhy I'm telling friends to avoid gold stocksBack in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."December 16, 2024 | DTI (Ad)iShares iBonds Dec 2027 Term Corporate ETF declares monthly distribution of $0.0881September 2, 2024 | msn.comiShares iBonds Dec 2027 Term Co (^IBDS-IV)August 21, 2024 | finance.yahoo.comiShares iBonds Dec 2027 Term Corporate ETF declares monthly distribution of $0.0839March 4, 2024 | msn.comSee More Headlines IBDS ETF - Frequently Asked Questions How have IBDS shares performed this year? iShares iBonds Dec 2027 Term Corporate ETF's stock was trading at $23.93 on January 1st, 2024. Since then, IBDS stock has increased by 0.5% and is now trading at $24.04. View the best growth stocks for 2024 here. Who are iShares iBonds Dec 2027 Term Corporate ETF's major shareholders? iShares iBonds Dec 2027 Term Corporate ETF's top institutional shareholders include Arrow Financial Corp (0.57%), Captrust Financial Advisors (0.42%), Lyell Wealth Management LP (0.36%) and Peloton Wealth Strategists (0.30%). How do I buy shares of iShares iBonds Dec 2027 Term Corporate ETF? Shares of IBDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of iShares iBonds Dec 2027 Term Corporate ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that iShares iBonds Dec 2027 Term Corporate ETF investors own include Garmin (GRMN), Kinsale Capital Group (KNSL), WPP (WPP), Pan American Silver (PAAS), Principal Financial Group (PFG), Invesco NASDAQ 100 ETF (QQQM) and Vertex Pharmaceuticals (VRTX). Fund Details IssueriShares Fund NameiShares iBonds Dec 2027 Term Corporate ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:IBDS Inception Date9/12/2017 Fund ManagerJames Mauro, Scott Radell WebN/A PhoneN/AFund Focus Asset ClassFixed Income BenchmarkBloomberg December 2027 Maturity Corporate Index (USD) CategoryCorporate FocusInvestment Grade Development LevelDeveloped Markets RegionNorth America Number of Holdings664 Fund Statistics Assets Under Management$2.70 billion Average Daily Volume$448,376.00 Discount/Premium0.02% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorBlackRock Fund Advisors CustodianState Street Bank and Trust Company DistributorBlackRock Investments, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerVirtu Financial Options OptionableN/A Short Interest278,300 shs Miscellaneous Outstanding Shares97,550,000Beta0.12 Creation Unit50,000 Creation Fee$300.00 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report Top 10 IBDS HoldingsCitigroup Inc. 4.45%Holding Weight: 0.72%T-Mobile USA, Inc. 3.75%Holding Weight: 0.72%WarnerMedia Holdings Inc. 3.755%Holding Weight: 0.71%Microsoft Corp. 3.3%Holding Weight: 0.68%Amazon.com, Inc. 3.15%Holding Weight: 0.61%Goldman Sachs Group, Inc. 3.85%Holding Weight: 0.56%Morgan Stanley 3.625%Holding Weight: 0.55%Verizon Communications Inc. 4.125%Holding Weight: 0.55%Broadcom Corporation/Broadcom Cayman Finance Ltd 3.875%Holding Weight: 0.53%Oracle Corp. 3.25%Holding Weight: 0.49%Full Holdings DetailsIBDS Sector ExposureIBDS Industry Exposure This page (NYSEARCA:IBDS) was last updated on 12/16/2024 by MarketBeat.com Staff From Our PartnersMedia Is Mocking Elon, But Wait Until They See This DemoElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredWall Street Icon: “If you wait on this, it will already be too late”...Investing legend Louis Navellier warned us about the stock market crash of 1987... the 2000 dot-com crash… Enr...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored"This looks and feels like 2000," says investing legendOur senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says i...Stansberry Research | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares iBonds Dec 2027 Term Corporate ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares iBonds Dec 2027 Term Corporate ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBDS Stock Alerts